Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Christenson

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 26, 2007
Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzerMegan A Griffey, Karl G Hock, Daniel C Kilgore, et al.
Annals of Emergency Medicine|August 12, 2008
A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trialRichard J Ryan, Christopher J Lindsell, Judd E Hollander, et al.
AIDS (London, England)|December 21, 2023
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIVSeth Himelhoch, Deana Kelly, Chris deFilippi, et al.
Frontiers in Cardiovascular Medicine|February 27, 2023
Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosisChristopher R deFilippi, Henry Tran, Raghav Gattani, et al.
ACS Combinatorial Science|April 26, 2019
Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung CancerMichael N Kammer, Amanda K Kussrow, Rebekah L Webster, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control- National Health and Nutrition Examination Survey, 1999-2004Natalie R Daya, John W McEvoy, Robert Christenson, et al.
The American Journal of Cardiology|September 18, 2020
Relation of Biomarkers of Cardiac Injury, Stress, and Fibrosis With Cardiac Mechanics in Patients ≥ 65 Years of AgeJohn S Gottdiener, Stephen Seliger, Christopher deFilippi, et al.
Critical Pathways in Cardiology|May 14, 2021
Prognostic Utility of a Modified HEART Score When Different Troponin Cut Points Are UsedLindsey Aurora, James McCord, Richard Nowak, et al.
JACC. Heart Failure|May 19, 2015
Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study)Stephen L Seliger, James de Lemos, Ian J Neeland, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 17, 2011
Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass graftingEmily C Esposito, Judd E Hollander, Richard J Ryan, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 26, 2007
Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzerMegan A Griffey, Karl G Hock, Daniel C Kilgore, et al.
Annals of Emergency Medicine|August 12, 2008
A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trialRichard J Ryan, Christopher J Lindsell, Judd E Hollander, et al.
AIDS (London, England)|December 21, 2023
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIVSeth Himelhoch, Deana Kelly, Chris deFilippi, et al.
Frontiers in Cardiovascular Medicine|February 27, 2023
Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosisChristopher R deFilippi, Henry Tran, Raghav Gattani, et al.
ACS Combinatorial Science|April 26, 2019
Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung CancerMichael N Kammer, Amanda K Kussrow, Rebekah L Webster, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control- National Health and Nutrition Examination Survey, 1999-2004Natalie R Daya, John W McEvoy, Robert Christenson, et al.
The American Journal of Cardiology|September 18, 2020
Relation of Biomarkers of Cardiac Injury, Stress, and Fibrosis With Cardiac Mechanics in Patients ≥ 65 Years of AgeJohn S Gottdiener, Stephen Seliger, Christopher deFilippi, et al.
Critical Pathways in Cardiology|May 14, 2021
Prognostic Utility of a Modified HEART Score When Different Troponin Cut Points Are UsedLindsey Aurora, James McCord, Richard Nowak, et al.
JACC. Heart Failure|May 19, 2015
Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study)Stephen L Seliger, James de Lemos, Ian J Neeland, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 17, 2011
Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass graftingEmily C Esposito, Judd E Hollander, Richard J Ryan, et al.
Pageof 8